they say glaxo is going to give amgen royalties down the road and others. so it appeared out of the blue. on the conference call, chairman and ceo said that this is the result of months of intense conversations with glaxo smith cline. >> we'll twittering the conference call for us. you can follow all of mike's comments at twitter.com/cnbc fast money. >> and long before that, karen finerman, timmy, you may, as well -- giving you love, as well. they told you to buy amgen, as well. here's the trade, you've got to understand august 13th is the next important date. you're going to have a lot of hot money, come in, chase this stock, i'll tell you what, you've got to be out, i believe ahead of august 13th. >> out or use the puts, the fact that all of this news that's already come out, that volatility will come in as you were talking about today. why did we see that rise? because of the catalyst. >> let's stay with health care right now. time for a sector trade on the insurers. aetna got hit throughout the session, lower by 3% after slashing the full-year earnings

lilly and glaxo are down while pfizer is up. but just barely now. shares of the world's biggest drug company are well off their intraday high. look at that chart. even though the company raised its revenue and earnings guidance for the full year and it's been a very choppy trading session for eli lilly, even though it too boosted its profit forecast and had that healthy ten-cent beat. but lilly will soon have a new top and bottom line contribution in the u.s. from the blood thinner e thinner eph yent, which the fda finally approved after several delays. lilly said it will lunch it in august as the potential competitor to plavix. but it's only approved for a certain population of patients and it has a stiff safety warning. it's a risk-benefit equation but of course the cost benefit analysis is a big part of the health care debate. and in a "first on cnbc" interview on "squawk box" this morning lilly's ceo said the company supports health care reform but hopes washington will find a happy medium. >> we do believe that we need to improve access to heal

glaxo cancelled half a billion dollars.n this planet has been negatively affected by the fact that medical research -- and it was cheaper to buy another pharmaceutical company than build -- >> so what are you saying? >> i think -- >> if we had a public plan, what does that do to innovation, investment? >> exactly. >> if we become a major public plan, what happens to innovation? >> that was dr. bill frist there along with the other panelists. hope you'll join us tonight for the premiere of "meeting of the minds: the future of health care." that's tonight at 9:00 p.m. eastern, 10:00 pacific on cnbc. and bob, one of the issues with obesity, i just want to make sure we're clear here, is the fact that an obese person can cost a company four times more than a smoker. why? because that person will typically develop diabetes and heart disease. >> that's a shocking figure, the one that milken used. $1 trillion if we just go back to the early levels, the levels of 1990 in terms of weight for the average american. shocking number. >>

it is upping full-year guidance and announced a deal with glaxo under which glaxo would commercializes drug. >> that stock gets into the 40s, i see it there, i say will it happen again? there seems to be these reasons not to know whether it's medicare reimbursements, whatever it is, but there it is, back up to 62. >> rent-a-center. i used that once. >> you did? >> you can rent to own. it was either rent-a-center or a competitor. >> what was -- >> i just got a couch, a table, and i think i bought my own tv. but i had a couch and table. you pay rent each month and you can end up owning this stuff or give it back. >> that's good in an environment where there's not a lot of new household creation. >> yes. you can see that it was well above expectations. i guess it makes sense in this economy. up 66 cents after hours. 61 cents, eight cents ahead of expectations. revenue was slightly short. full year's earning guidance at the top of the street's expectations. >> when this is all over, are you going to miss this? miss coming over here? >> i have a feeling that, unfortunately, there are compa

. >>> glaxo smith kin is negotiating a vaccine with the swine flu. they are working frantically to meet demand. the h1n1 virus is spreading around the globe. 429 people have died from the virus globally. >>> this comes as british airways told its check-in staff to tell people to look out for passengers showing signs of the illness. >> microsoft expected to report the first annual sales dip in its history as a publicly traded company this week. investors were looking for a bullish outlook from the company to help try to maintain that momentum that we saw. shares pushed up 63% since march. investors will look for comments on just how windows 7 is doing. also on a potential deal, yes, we keep hearing about it, about yahoo! and microsoft doing a search tie-up. that's like the never-ending soap opera. >>> aol's chief executive is urging investors to hold on to the company's shares until 2011. aol could be spun off again from time warner later this year. this after a 100-day review of the country. tim armstrong is saying stock hoerlds should cash in on wha

barges corp., wells fargo, glaxo smith line, altria, bank of new york melon and delta air lines.e have plenty of stuff happening today. shares of boeing down about 37% just in the last year even though they have rallied almost 17% since mid april. the aerospace giant is expected to post an increase in profit year over year earning $1.21 a share. revenues expected to rise by 1% to $17.2 billion. as for pfizer, it is expected to earn 47 cents a share on revenue of $11.3 billion. so how about the dow 30? >> let's go to the heat map. >> let's go to the heat map. you will see how they are performing this season. >> versus expectation peps and remember, a lot of these companies reported earnings down from a year ago. there have been a couple who have been a little better than a year ago. but as you can see, every single one of the dow components that have reported so far have been above expectations. so 12 so far. >> yes. dupont down 61%. caterpillar down 66%. so many are above, but -- i mean are below, but above -- >> well, the market -- whoa. what is this one? >> this is actual versu

amgen also struck a deal to have glaxo smithkline market an experimental osteoporosis drug waiting fda approval in europe. in frankfurt amgen is trading up nearly 3%. if you want to know more, check out the pharma blog. mike huckman writes about the latest and greatest breaking news in that sector. for everything else check news and video on cnbc.com. >>> still to come on today's program, deutsche bank posted solid second quarter earnings but has raised its provisions for bad loans. we will break down those numbers. chi china's biggest ipo this year will happen tomorrow. and bp has had a 53% drop in its second quarter of costs. at 155 miles per hour, andy roddick has the fastest serve in the history of professional tennis. so i've come to this court to challenge his speed. ...on the internet. i'll be using the 3g at&t laptopconnect card. he won't so i can book travel plans faster, check my account balances faster. all on the go. i'm bill kurtis and i'm faster than andy roddick. (announcer) "switch to the nations fastest 3g network" "and get the at&t laptopconnect card for free". >>> ov